Tricuspid regurgitation cardiac MRI: Difference between revisions
Jump to navigation
Jump to search
| Line 10: | Line 10: | ||
* [[Cardiac magnetic resonance|Cardiac MRI]] is useful in evaluating the structure and function of the [[right atrium]] and [[right ventricle]] as well as the severity of the [[tricuspid regurgitation]], especially when [[echocardiography]] is inconclusive. | * [[Cardiac magnetic resonance|Cardiac MRI]] is useful in evaluating the structure and function of the [[right atrium]] and [[right ventricle]] as well as the severity of the [[tricuspid regurgitation]], especially when [[echocardiography]] is inconclusive. | ||
* Findings on MRI suggestive of/diagnostic of [[tricuspid regurgitation]] include: | * Findings on MRI suggestive of/diagnostic of [[tricuspid regurgitation]] include: | ||
**[[Cardiac magnetic resonance|Cardiac magnetic resonance imaging]] ([[CMR]]) helps in giving the quantitative assessment of tricuspid regurgitant volume | |||
**[[Cardiac magnetic resonance|Cardiac magnetic resonance imaging]] ([[CMR]]) helps in estimation of regurgitant fraction | |||
**[[Cardiac magnetic resonance|Cardiac magnetic resonance imaging]] ([[CMR]]) helps in estimation of RV volumes and ejection fraction | |||
**[[Cardiac magnetic resonance|Cardiac magnetic resonance imaging]] ([[CMR]]) helps in evaluation of associated left ventricle and mitral disease | |||
==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= 129 | issue= 23 | pages= 2440-92 | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref>== | ==2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary<ref name="pmid24589852">{{cite journal| author=Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA et al.| title=2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. | journal=Circulation | year= 2014 | volume= 129 | issue= 23 | pages= 2440-92 | pmid=24589852 | doi=10.1161/CIR.0000000000000029 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24589852 }} </ref>== | ||
Revision as of 18:39, 22 April 2020
|
Tricuspid Regurgitation Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tricuspid regurgitation cardiac MRI On the Web |
|
American Roentgen Ray Society Images of Tricuspid regurgitation cardiac MRI |
|
Risk calculators and risk factors for Tricuspid regurgitation cardiac MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]
Overview
Cardiac magnetic resonance imaging (CMR) may be beneficial when echocardiography findings are inconclusive, particularly before tricuspid valve surgery.[1]
Cardiac MRI
- Cardiac MRI is useful in evaluating the structure and function of the right atrium and right ventricle as well as the severity of the tricuspid regurgitation, especially when echocardiography is inconclusive.
- Findings on MRI suggestive of/diagnostic of tricuspid regurgitation include:
- Cardiac magnetic resonance imaging (CMR) helps in giving the quantitative assessment of tricuspid regurgitant volume
- Cardiac magnetic resonance imaging (CMR) helps in estimation of regurgitant fraction
- Cardiac magnetic resonance imaging (CMR) helps in estimation of RV volumes and ejection fraction
- Cardiac magnetic resonance imaging (CMR) helps in evaluation of associated left ventricle and mitral disease
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary[1]
| Class IIb |
| "1. CMR or real-time 3-dimensional echocardiography may be considered for assessment of RV systolic function and systolic and diastolic volumes in patients with severe TR (stages C and D) and suboptimal 2-dimensional echocardiograms. (Level of Evidence: C)" |
References
- ↑ 1.0 1.1 Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Guyton RA; et al. (2014). "2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines". Circulation. 129 (23): 2440–92. doi:10.1161/CIR.0000000000000029. PMID 24589852.